Breast Cancer Survivorship

1. Front Matter

   Pages i-xv

   PDF

2. Introduction

   • David Okonji, Alistair Ring

   Pages 1-12

3. Disease Recurrence

   1. Front Matter

      Pages 13-13

      PDF

   2. Predicting Risk of Disease Recurrence

      • Belinda Yeo

      Pages 15-30

   3. Detection of Recurrence: Clinical Follow-Up

      • Anne Mc Loughlin, Nicola Roche

      Pages 31-40

   4. Detection of Recurrence: Imaging Strategies

      • Kate Downey, Steven Allen

      Pages 41-51

   5. Follow Up of Patients with Germline Mutations in High Risk Predisposition Genes

      • Zoe Kemp

      Pages 53-63

4. Interventions to Reduce Risk of Recurrence

   1. Front Matter

      Pages 65-65

      PDF

   2. Endocrine Therapy

      • Stefania Redana

      Pages 67-82

   3. Systemic Therapies to Reduce the Risk of Recurrence in Early Breast Cancer: New Strategies

      • Narda Chaabouni, Christos Nikolaou, Mark Harries

      Pages 83-91

   4. Exercise in Breast Cancer Survivors

      • Nawa Mustafa Amin, Alistair Ring

      Pages 93-102

   5. Dietary Components and Breast Cancer Survivorship

      • Clare Shaw

      Pages 103-113

5. Sequelae of Early Breast Cancer and Its Treatment

   1. Front Matter

      Pages 115-115

      PDF

   2. Identifying and Managing the Consequences of Treatment for Early Breast Cancer

      • Natalie Doyle, Nicola Cunningham, Richard Henry

      Pages 117-126

   3. Managing Loco-regional Complications of Breast Cancer Treatment

      • Anna M. Kirby

      Pages 127-138

   4. The Role of Surgery in Breast Cancer Survivors

      • Rachel L. O’Connell, Jennifer E. Rusby

      Pages 139-152

   5. Management of Menopausal Symptoms in Breast Cancer Survivors

      • Helen Mitchell, Anne C. Armstrong

      Pages 153-164

   6. Bone Health

      • Amy Kwan, Omar S. Din, Matthew C. Winter

      Pages 165-178

   7. Fertility

      • Stuart Lavery, Georgios Christopoulos

      Pages 179-191

   8. Cardiotoxicity in Breast Cancer Survivors

      • Nilesh Pareek, Susannah Stanway, Anna M. Kirby, Alexander Lyon

      Pages 193-212

This book discusses the impact on women of the diagnosis and treatment of early breast cancer. Readers will learn about the risks of breast cancer recurrence and interventions to reduce these, such as endocrine therapy and bisphosphonate therapy, as well as the role of lifestyle factors such as diet and exercise. The long-term effects of treatment on fertility, the heart and other systems are discussed, as well the  psychological burden for women who are increasingly likely to be cured from their cancer.  Each chapter provides background and a  practical guide in the management of women after the initial phase of diagnosis and treatment.

Authored by a multidisciplinary team this book provides all the relevant expertise as well as different perspectives, providing a holistic picture of early breast cancer consequences.

From oncologists to general practitioners as well as specialist nurses, gynaecologists, psychologists and other healthcare professionals  involved in the long-term care of women with breast cancer, this book provides a timely and indispensable guide to practitioners caring for early breast cancer survivors.

• chemotherapy
• late effects
• psycho oncology
• recurrence
• sequelae

• The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  Alistair Ring

• The Royal Marsden NHS Foundation Trust, London, United Kingdom

  Marina Parton

Dr Ring is a consultant in medical oncology at the Royal Marsden Hospital. He undertook his pre-clinical training at the University of Cambridge and clinical training at the University of Oxford, qualifying in 1997. His oncology training was based at the Royal Marsden, St George’s and Guy’s Hospitals, London. He gained his MD research degree in 2005 from the Institute of Cancer Research at the University of London. In 2008 he was appointed as Senior Lecturer in Oncology at Brighton and Sussex Medical School, where he held various roles including Director of the Brighton NIHR Clinical Research Facility. In 2014 he was appointed Consultant in Medical Oncology at the Royal Marsden Hospital.

He has a specialist interests in the management of metastatic and early breast cancer and the management of cancer in older patients. He has a major interest in research, and is UK lead for a study which will investigate the role of aspirin in the treatment of over 3000 women with early breast cancer. He is Chair of the Committee for Clinical Research at the Royal Marsden Hospital and Institute of Cancer Research. Dr Ring has published widely in peer-reviewed journals and in 2015 edited the textbook “Problem-solving in older cancer patients.”

He is a member of the National Cancer Research Institute (NCRI) Breast Clinical Studies Group, and chair of the NCRI Advanced Breast Cancer subgroup, which oversees trials for advanced breast cancer in the UK. He is a member of the American Society of Clinical Oncology. 

Dr Marina Parton is a Medical Oncologist in Breast Cancer at The Royal Marsden and Kingston Hospitals. Appointed to The Royal Marsden Consultant body in 2009, she received her oncology training at The Royal Marsden and carried out her research in neoadjuvant therapy in breast cancer as part of a MD at The Institute of Cancer Research at the University of London. 

Dr Parton is Lead Cancer Clinician in The Royal Marsden's first satellite chemotherapy unit, a joint venture with Kingston Hospital and Macmillan Cancer Support. She has chaired and taken part in groups within  the London Cancer Alliance for the Breast pathway, Chemotherapy Closer to Home, Menopausal Symptoms Management and Sexuality and Consequences of Therapy. She has led on a number of projects delivering care closer to home, and the development of Acute Oncology at cancer centres and cancer units. Dr Parton has been PI to a  number of national and international studies in early breast cancer, and has published in peer-reviewed international journals. 

<